Post-stroke Delirium in Ischemic Stroke Patients

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

COMPLETED

Total Enrollment

985 participants

Study Classification

OBSERVATIONAL

Study Start Date

2021-09-01

Study Completion Date

2023-04-27

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

This study is to investigate the predictors of post-stroke delirium, develop and validate a nomogram of post-stroke delirium in the ischemic stroke patients.

Related Clinical Trials

Explore similar clinical trials based on study characteristics and research focus.

Post-stroke Cognitive Impairment

NCT05653141

First-ever Ischemic Stroke Cognitive Performance

ACTIVE_NOT_RECRUITING

Development and Validation of the Prediction Model for Cognitive Impairment

NCT05465980

Stroke, Acute

UNKNOWN

Gut Microbiota and Serum Markers for Cognitive Impairment and Poor Prognosis After Ischemic Stroke

NCT04688138

Ischemic Stroke

UNKNOWN

Stroke Registration of Young Adults in China

NCT03024164

Ischemic Stroke

RECRUITING

Cohort Study for Severe Ischaemic Stroke

NCT03222024

Severe Ischaemic Stroke Malignant Ischaemic Stroke

COMPLETED

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Introduction: Post-stroke delirium (PSD) is associated with unfavorable prognosis. Effectively identifying risk factors of PSD and predicting PSD is of essential.

Methods: This is a prospective, single-centered, cohort study.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Ischemic Stroke

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Observational Model Type

COHORT

Study Time Perspective

PROSPECTIVE

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

with post-stroke delirium

ischemic stroke patients with post-stroke delirium

Test delirium state

Intervention Type DIAGNOSTIC_TEST

use scale to test whether ischemic stroke patients have post-stroke delirium

without post-stroke delirium

ischemic stroke patients without post-stroke delirium

Test delirium state

Intervention Type DIAGNOSTIC_TEST

use scale to test whether ischemic stroke patients have post-stroke delirium

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

Test delirium state

use scale to test whether ischemic stroke patients have post-stroke delirium

Intervention Type DIAGNOSTIC_TEST

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

1. aged ≥18 years old;(2) ischemic stroke, confirmed by computed tomography (CT) or magnetic resonance imaging (MRI) scans;(3) patients or their agencies agree to participate in this study.

Exclusion Criteria

1. brain dysfunction caused by non-vascular causes such as traumatic brain injury, brain tumor or metastatic brain tumor;(2) history of serious mental illness such as schizophrenia;(3) unable to cooperate to the assessment as deafness, blindness, aphasia, dysarthria;(4) be in coma \[Glasgow Coma Scale (GCS)≤8 points\] or sedation \[Richmond Agitation Sedation Scale (RASS)\<-3 points\], and do not ameliorate during study;(5) with incomplete data.

Minimum Eligible Age

18 Years

Maximum Eligible Age

100 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

No